BlackRock Fund Advisors - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 103 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$21,533,000
+61.3%
3,401,744
+12.4%
0.00%
+33.3%
Q3 2016$13,352,000
+64.9%
3,027,595
+6.2%
0.00%
+50.0%
Q2 2016$8,095,000
+2.1%
2,850,238
+1.8%
0.00%0.0%
Q1 2016$7,926,000
-72.5%
2,800,786
+0.4%
0.00%
-71.4%
Q4 2015$28,789,000
-13.3%
2,789,584
-4.2%
0.01%
-22.2%
Q3 2015$33,194,000
-21.3%
2,911,728
+3.1%
0.01%
-10.0%
Q2 2015$42,158,000
+63.2%
2,823,718
-1.3%
0.01%
+66.7%
Q1 2015$25,834,000
-24.2%
2,860,900
+2.0%
0.01%
-25.0%
Q4 2014$34,103,000
+36.8%
2,804,541
+10.1%
0.01%
+14.3%
Q3 2014$24,921,000
-23.6%
2,548,170
-0.4%
0.01%
-22.2%
Q2 2014$32,616,000
+243.3%
2,558,112
+184.8%
0.01%
+200.0%
Q1 2014$9,502,000
+49.8%
898,132
+7.6%
0.00%
+50.0%
Q4 2013$6,344,000
+487.4%
834,789
+462.8%
0.00%
Q3 2013$1,080,000
+462.5%
148,335
+19.6%
0.00%
Q2 2013$192,000123,9850.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
DG Capital Management, LLC 1,186,726$4,076,0002.45%
Sarissa Capital Management LP 4,861,000$16,697,0001.97%
Ghost Tree Capital, LLC 1,950,000$6,698,0001.94%
ORACLE INVESTMENT MANAGEMENT INC 2,525,857$8,676,0001.14%
Eversept Partners, LP 1,143,211$3,926,9300.87%
DAFNA Capital Management LLC 749,051$2,573,0000.84%
KNOTT DAVID M 397,361$1,365,0000.80%
Parkman Healthcare Partners LLC 800,740$2,751,0000.73%
ACUTA CAPITAL PARTNERS, LLC 660,000$2,267,0000.62%
Formidable Asset Management, LLC 578,200$1,949,0000.57%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders